Ordinary Index Rebalancing in the Solactive Diabetes Performance-Index | September 2021

In the ordinary rebalance the following composition will be implemented effective open 13.09.2021:

ABBOTT LABORATORIES
APPLIED THERAPEUTICS INC
CONVATEC GROUP PLC
DARIOHEALTH CORP
DEXCOM INC
DIAMYD MEDICAL AB
EKF DIAGNOSTICS HOLDINGS PLC
ELI LILLY & CO
INSULET CORP
KALVISTA PHARMACEUTICALS INC
LEXICON PHARMACEUTICALS INC
MANNKIND CORP
NOVO NORDISK A/S
OPTHEA LTD
ORAMED PHARMACEUTICALS INC
POXEL SA
PROVENTION BIO INC
SENSEONICS HOLDINGS INC
SERNOVA CORP
Sigilon Therapeutics Inc
TANDEM DIABETES CARE INC
YPSOMED HOLDING AG
ZEALAND PHARMA A/S